Erratum: Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1 (Journal of Lipid Research (2012) 53 (2390-2404) DOI: 10.1194/jlr.M029314);Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1

Journal of Lipid Research

Volumn 53, Issue 11, 2012, Pages 2390-2404

  Turner, Elizebeth C ^a   Kinsella, B Therese ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROSTACYCLIN RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A;

ARTICLE; BINDING AFFINITY; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; LIPID ANALYSIS; MEGAKARYOBLAST; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROSTACYCLIN RECEPTOR GENE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; RECEPTOR GENE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VASCULAR ENDOTHELIUM;

EID: 84867393447     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/JLR.M029314ERR2     Document Type: Erratum

References (70)

1. Gryglewski, R. J. 2008. Prostacyclin among prostanoids. Pharmacol. Rep. 60: 3-11. (Pubitemid 351586537)
2. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79: 1193-1226. (Pubitemid 29473315)
3. Kawabe, J., F. Ushikubi, and H. Hasebe. 2010. Prostacyclin in vascular diseases. - Recent insights and future perspectives -. Circ. J. 74: 836-843.
4. Hayes, J. S., O. A. Lawler, M. T. Walsh, and B. T. Kinsella. 1999. The prostacyclin receptor is isoprenylated. Isoprenylation is required for efficient receptor-effector coupling. J. Biol. Chem. 274: 23707-23718.
5. Miggin, S. M., O. A. Lawler, and B. T. Kinsella. 2003. Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation. J. Biol. Chem. 278: 6947-6958. (Pubitemid 36800688)
6. O'Keeffe, M. B., H. M. Reid, and B. T. Kinsella. 2008. Agonist-dependent internalization and trafficking of the human prostacyclin receptor: a direct role for Rab5a GTPase. Biochim. Biophys. Acta. 1783: 1914-1928.
7. Reid, H. M., E. P. Mulvaney, E. C. Turner, and B. T. Kinsella. 2010. Interaction of the human prostacyclin receptor with Rab11: characterization of a novel Rab11 binding domain within alpha-helix 8 that is regulated by palmitoylation. J. Biol. Chem. 285: 18709-18726.
8. Turner, E. C., E. P. Mulvaney, H. M. Reid, and B. T. Kinsella. 2011. Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis. Mol. Biol. Cell. 22: 2664-2679.
9. Wikström, K., H. M. Reid, M. Hill, K. A. English, M. B. O'Keeffe, C. C. Kimbembe, and B. T. Kinsella. 2008. Recycling of the human prostacyclin receptor is regulated through a direct interaction with Rab11a GTPase. Cell. Signal. 20: 2332-2346.
10. Wilson, S. J., and E. M. Smyth. 2006. Internalization and recycling of the human prostacyclin receptor is modulated through its isoprenylation- dependent interaction with the delta subunit of cGMP phosphodiesterase 6. J. Biol. Chem. 281: 11780-11786. (Pubitemid 43855437)
11. Fitzgerald, D. J., S. S. Entman, K. Mulloy, and G. A. FitzGerald. 1987. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation. 75: 956-963. (Pubitemid 17068524)
12. Kahn, N. N., H. S. Mueller, and A. K. Sinha. 1990. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease. Circ. Res. 66: 932-940. (Pubitemid 20126424)
13. Kömhoff, M., B. Lesener, K. Nakao, H. W. Seyberth, and R. M. Nusing. 1998. Localization of the prostacyclin receptor in human kidney. Kidney Int. 54: 1899-1908.
14. Gomberg-Maitland, M., and H. Olschewski. 2008. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur. Respir. J. 31: 891-901.
15. Fetalvero, K. M., K. A. Martin, and J. Hwa. 2007. Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins Other Lipid Mediat. 82: 109-118. (Pubitemid 44895439)
16. Sakai, A., M. Yajima, and S. Nishio. 1990. Cytoprotective effect of TRK-100, a prostacyclin analogue, against chemical injuries in cultured human vascular endothelial cells. Life Sci. 47: 711-719. (Pubitemid 20262153)
17. Xiao, C. Y., A. Hara, K. Yuhki, T. Fujino, H. Ma, Y. Okada, O. Takahata, T. Yamada, T. Murata, S. Narumiya, et al. 2001. Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation. 104: 2210-2215. (Pubitemid 33043302)
18. Zachary, I. 2001. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am. J. Physiol. Cell Physiol. 280: C1375-C1386. (Pubitemid 32553192)
19. Patrignani, P., C. Di Febbo, S. Tacconelli, K. Douville, M. D. Guglielmi, R. J. Horvath, M. Ding, K. Sierra, J. Stitham, S. Gleim, et al. 2008. Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study. Pharmacogenet. Genomics. 18: 611-620.
20. Stitham, J., E. J. Arehart, S. Gleim, K. Douville, T. MacKenzie, and J. Hwa. 2007. Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR). Gene. 396: 180-187. (Pubitemid 46818789)
21. Stitham, J., A. Stojanovic, and J. Hwa. 2002. Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism. J. Biol. Chem. 277: 15439-15444. (Pubitemid 34967808)
22. Arehart, E., J. Stitham, F. W. Asselbergs, K. Douville, T. MacKenzie, K. M. Fetalvero, S. Gleim, Z. Kasza, Y. Rao, L. Martel, et al. 2008. Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ. Res. 102: 986-993. (Pubitemid 351591551)
23. Stitham, J., E. Arehart, L. Elderon, S. R. Gleim, K. Douville, Z. Kasza, K. Fetalvero, T. MacKenzie, J. Robb, K. A. Martin, et al. 2011. Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction. J. Biol. Chem. 286: 7060-7069.
24. Bley, K. R., J. C. Hunter, R. M. Eglen, and J. A. Smith. 1998. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol. Sci. 19: 141-147. (Pubitemid 28218537)
25. Hoshikawa, Y., N. F. Voelkel, T. L. Gesell, M. D. Moore, K. G. Morris, L. A. Alger, S. Narumiya, and M. W. Geraci. 2001. Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. Am. J. Respir. Crit. Care Med. 164: 314-318. (Pubitemid 34001301)
26. Murata, T., F. Ushikubi, T. Matsuoka, M. Hirata, A. Yamasaki, Y. Sugimoto, A. Ichikawa, Y. Aze, T. Tanaka, N. Yoshida, et al. 1997. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 388: 678-682. (Pubitemid 27366439)
27. Stitham, J., E. J. Arehart, S. R. Gleim, K. L. Douville, and J. Hwa. 2007. Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations. Prostaglandins Other Lipid Mediat. 82: 95-108. (Pubitemid 44880168)
28. Sugimoto, Y., S. Narumiya, and A. Ichikawa. 2000. Distribution and function of prostanoid receptors: studies from knockout mice. Prog. Lipid Res. 39: 289-314. (Pubitemid 30336470)
29. Kawabe, J., K. Yuhki, M. Okada, T. Kanno, A. Yamauchi, N. Tashiro, T. Sasaki, S. Okumura, N. Nakagawa, Y. Aburakawa, et al. 2010. Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 30: 464-470.
30. Egan, K. M., J. A. Lawson, S. Fries, B. Koller, D. J. Rader, E. M. Smyth, and G. A. Fitzgerald. 2004. COX-2-derived prostacyclin confers atheroprotection on female mice. Science. 306: 1954-1957. (Pubitemid 39627863)
31. Ospina, J. A., D. N. Krause, and S. P. Duckles. 2002. 17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke. 33: 600-605. (Pubitemid 34123413)
32. Turner, E. C., and B. T. Kinsella. 2010. Estrogen increases expression of the human prostacyclin receptor within the vasculature through an ERalpha-dependent mechanism. J. Mol. Biol. 396: 473-486 (Corrigendum, J. Mol. Biol. 2011; 413: 899).
33. Vogel, R. A. 1999. Cholesterol lowering and endothelial function. Am. J. Med. 107: 479-487. (Pubitemid 29528337)
34. Corsini, A., S. Bellosta, R. Baetta, R. Fumagalli, R. Paoletti, and F. Bernini. 1999. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol. Ther. 84: 413-428.
35. Guijarro, C., L. M. Blanco-Colio, M. Ortego, C. Alonso, A. Ortiz, J. J. Plaza, C. Diaz, G. Hernandez, and J. Egido. 1998. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ. Res. 83: 490-500. (Pubitemid 28411050)
36. Laufs, U., and J. K. Liao. 2000. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc. Med. 10: 143-148. (Pubitemid 32178190)
37. Arnaud, C., N. R. Veillard, and F. Mach. 2005. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 127-134. (Pubitemid 40645486)
38. Smith, L. H., O. Boutaud, M. Breyer, J. D. Morrow, J. A. Oates, and D. E. Vaughan. 2002. Cyclooxygenase-2-dependent prostacyclin formation is regulated by low density lipoprotein cholesterol in vitro. Arterioscler. Thromb. Vasc. Biol. 22: 983-988. (Pubitemid 34655227)
39. Smith, L. H., M. S. Petrie, J. D. Morrow, J. A. Oates, and D. E. Vaughan. 2005. The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells. J. Lipid Res. 46: 862-871.
40. Long, M. W., C. H. Heffner, J. L. Williams, C. Peters, and E. V. Prochownik. 1990. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J. Clin. Invest. 85: 1072-1084. (Pubitemid 20123748)
41. Suggs, J. E., M. C. Madden, M. Friedman, and C. J. Edgell. 1986. Prostacyclin expression by a continuous human cell line derived from vascular endothelium. Blood. 68: 825-829. (Pubitemid 17183839)
42. Turner, E. C., and B. T. Kinsella. 2009. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells. J. Mol. Biol. 386: 579-597.
43. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25: 402-408. (Pubitemid 34164012)
44. Liu, S., H. Luo, J. Liu, A. S. McNeilly, and S. Cui. 2008. Specificity protein 1 (Sp1) plays role in regulating LIM homeodomain transcription factor Lhx4 gene expression. Biochem. Biophys. Res. Commun. 366: 36-41. (Pubitemid 50008461)
45. Schroeder-Gloeckler, J. M., S. M. Rahman, R. C. Janssen, L. Qiao, J. Shao, M. Roper, S. J. Fischer, E. Lowe, D. J. Orlicky, J. L. McManaman, et al. 2007. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. J. Biol. Chem. 282: 15717-15729. (Pubitemid 47093283)
46. Smith, J. R., T. F. Osborne, J. L. Goldstein, and M. S. Brown. 1990. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J. Biol. Chem. 265: 2306-2310.
47. Keating, G. L., E. C. Turner, and B. T. Kinsella. 2012. Regulation of the human prostacyclin receptor gene in megakaryocytes: Major roles for C/EBPδ and PU.1. Biochim. Biophys. Acta. 1819: 428-445.
48. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23: 4878-4884. (Pubitemid 3008389)
49. Bengoechea-Alonso, M. T., and J. Ericsson. 2007. SREBP in signal transduction: cholesterol metabolism and beyond. Curr. Opin. Cell Biol. 19: 215-222. (Pubitemid 46386402)
50. Eberlé, D., B. Hegarty, P. Bossard, P. Ferre, and F. Foufelle. 2004. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 86: 839-848.
51. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131. (Pubitemid 34496588)
52. Horton, J. D., N. A. Shah, J. A. Warrington, N. N. Anderson, S. W. Park, M. S. Brown, and J. L. Goldstein. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA. 100: 12027-12032. (Pubitemid 37271509)
53. Osborne, T. F., and P. J. Espenshade. 2009. Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been. Genes Dev. 23: 2578-2591.
54. Jeon, T. I., and T. F. Osborne. 2012. SREBPs: metabolic integrators in physiology and metabolism. TEM. 23: 65-72.
55. Shimomura, I., H. Shimano, B. S. Korn, Y. Bashmakov, and J. D. Horton. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 273: 35299-35306. (Pubitemid 29028238)
56. Sanchez, H. B., L. Yieh, and T. F. Osborne. 1995. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J. Biol. Chem. 270: 1161-1169.
57. Krycer, J. R., L. J. Sharpe, W. Luu, and A. J. Brown. 2010. The Akt-SREBP nexus: cell signaling meets lipid metabolism. TEM. 21: 268-276.
58. Du, X., I. Kristiana, J. Wong, and A. J. Brown. 2006. Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol. Biol. Cell. 17: 2735-2745. (Pubitemid 43825509)
59. Tyroler, H. A. 1985. Total serum cholesterol and ischemic heart disease risk in clinical trials and observational studies. Am. J. Prev. Med. 1: 18-24. (Pubitemid 15017492)
60. Hadi, H. A., C. S. Carr, and J. Al Suwaidi. 2005. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc. Health Risk Manag. 1: 183-198.
61. Seo, Y. K., T. I. Jeon, H. K. Chong, J. Biesinger, X. Xie, and T. F. Osborne. 2011. Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy. Cell Metab. 13: 367-375.
62. Dawson, P. A., S. L. Hofmann, D. R. van der Westhuyzen, T. C. Sudhof, M. S. Brown, and J. L. Goldstein. 1988. Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J. Biol. Chem. 263: 3372-3379. (Pubitemid 18072796)
63. Briggs, M. R., C. Yokoyama, X. Wang, M. S. Brown, and J. L. Goldstein. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J. Biol. Chem. 268: 14490-14496. (Pubitemid 23195580)
64. Yokoyama, C., X. Wang, M. R. Briggs, A. Admon, J. Wu, X. Hua, J. L. Goldstein, and M. S. Brown. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 75: 187-197. (Pubitemid 23306032)
65. Amemiya-Kudo, M., H. Shimano, A. H. Hasty, N. Yahagi, T. Yoshikawa, T. Matsuzaka, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, et al. 2002. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J. Lipid Res. 43: 1220-1235. (Pubitemid 34988170)
66. Smith, J. R., T. F. Osborne, M. S. Brown, J. L. Goldstein, and G. Gil. 1988. Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J. Biol. Chem. 263: 18480-18487. (Pubitemid 19005124)
67. Edwards, P. A., D. Tabor, H. R. Kast, and A. Venkateswaran. 2000. Regulation of gene expression by SREBP and SCAP. Biochim. Biophys. Acta. 1529: 103-113.
68. Jeon, B. N., Y. S. Kim, W. I. Choi, D. I. Koh, M. K. Kim, J. H. Yoon, M. Y. Kim, B. Hur, P. D. Paik, and M. W. Hur. 2012. Kr-pok increases FASN expression by modulating the DNA binding of SREBP-1c and Sp1 at the proximal promoter. J. Lipid Res. 53: 755-766.
69. Guan, G., P. H. Dai, T. F. Osborne, J. B. Kim, and I. Shechter. 1997. Multiple sequence elements are involved in the transcriptional regulation of the human squalene synthase gene. J. Biol. Chem. 272: 10295-10302. (Pubitemid 27171712)
70. Sato, R., J. Inoue, Y. Kawabe, T. Kodama, T. Takano, and M. Maeda. 1996. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 271: 26461-26464. (Pubitemid 26359040)